Heart Valve Repair

April 7, 2014 — A first-ever randomized head-to-head comparison of two devices commonly used to treat aortic stenosis finds balloon-expandable transcatheter valves (such as the Edwards Sapien) result in more successful procedures and relieve sympt...

Edwards Lifesciences Corp. announced the successful completion of the first three human implants of its Fortis mitral transcatheter heart valve. The Heart Team...

Neovasc Inc. announced that a first-in-human implantation of its Tiara transcatheter mitral valve was successfully performed Jan. 30 by physicians at St. P...

transcatheter mitral valve replacement, Sapien used for Mitral valve

Doctors at Henry Ford Hospital in Detroit used an Edwards Lifesciences Sapien transcatheter aortic valve replacement (TAVR) device to repair a mitral va...

Boston Scientific Louts Tavi System CE mark Heart Repair
Boston Scientific Corp. received CE mark and began the European commercial launch of its new 25 mm Lotus transcatheter aortic valve implantation (...
DC Devices Inc. has closed a $34 million Series D financing round. Accelmed led the round with contributions from existing investors Third Rock Ventures,...
CardiAQ Valve Technologies (CardiAQ), a leader in the field of transcatheter mitral valve implantation (TMVI), announced that the European Patent Office Legal...
Researchers have announced the results of a study that used speckle-tracking echocardiography (STE) to analyze early phase one results from the multi-center...
Sapien XT, FDA
The Edwards Sapien XT transcatheter aortic heart valve is indicated for the treatment of high-risk and inoperable patients suffering from
Esaote North America and Pie Medical Imaging provide 3mensio Structural Heart software for cardiovascular planning solutions...
Medtronic’s self-expanding transcatheter aortic valve replacement (TAVR) CoreValve System is the first self-expanding TAVR valve...
MediValve Ltd.'s acWire Guidewire received Pre-Marketing Notification Application (510(k)) from the U.S. Food and Drug Administration (FDA...

Articles

Sapien XT, FDA
The U.S. Food and Drug Administration (FDA) approval for its Edwards Sapien XT transcatheter aortic heart valve for the treatment of high-risk and inoperable...
Watchman, LAA occluder
Interventional thought leaders at the American College of Cardiology (ACC) 2014 meeting shared their predictions about the cutting-edge technologies emerging...
Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the transaction is completed, Medtronic will have significantly...
Boston Scientific REPRISE II Clinical Trial Six-month Results Lotus Valve
Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corp. Lotus Valve System continued to...

Video Center

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
2 weeks 8 hours ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
2 weeks 6 days ago
The key cardiology news coming out of the 2014 meeting for the Society of Nuclear Medicine and...
4 weeks 6 days ago
CVIS, cardiovascular information system, webinar
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle efficiency benefits of a modern cardiovascular...
The webinar "Implementing Robotic PCI — Why and How to Start a Successful Program" defines optimal strategies for launching a successful robotic percutaneous coronary intervention (PCI) program. The...
This webinar focuses on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It offers an...